Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000024

CEO bought 48,000 shares at an average $0.01 ($676)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-15 Purchase : show line 1 in the form +2,000 $0.02 $33 21,017,123 D
2019-04-16 Purchase : show line 2 in the form +10,000 $0.02 $160 21,027,123 D
2019-04-17 Purchase : show line 3 in the form +2,000 $0.02 $32 21,029,123 D
2019-04-18 Purchase : show line 4 in the form +12,000 $0.01 $167 21,041,123 D
2019-04-18 Purchase : show line 5 in the form +2,000 $0.01 $29 21,043,123 D
2019-04-18 Purchase : show line 6 in the form +2,000 $0.01 $29 21,045,123 D
2019-04-18 Purchase : show line 7 in the form +2,000 $0.01 $29 21,047,123 D
2019-04-22 Purchase : show line 8 in the form +2,000 $0.01 $26 21,049,123 D
Open-market purchases · 48,000 sh · avg $0.01 · $676
Loading xslF345X03/primary_doc.xml…